Charles S. Berkman
2011 - Ligand Pharmaceuticals
In 2011, Charles S. Berkman earned a total compensation of $478.9K as Vice President and General Counsel at Ligand Pharmaceuticals, a 4% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $99,888 |
|---|---|
| Option Awards | $96,278 |
| Salary | $249,719 |
| Stock Awards | $30,150 |
| Other | $2,838 |
| Total | $478,873 |
Berkman received $249.7K in salary, accounting for 52% of the total pay in 2011.
Berkman also received $99.9K in non-equity incentive plan, $96.3K in option awards, $30.2K in stock awards and $2.8K in other compensation.
Rankings
In 2011, Charles S. Berkman's compensation ranked 8,193rd out of 10,747 executives tracked by ExecPay. In other words, Berkman earned more than 23.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,193 out of 10,747 | 24th |
Division Manufacturing | 3,016 out of 3,960 | 24th |
Major group Chemicals And Allied Products | 751 out of 1,038 | 28th |
Industry group Drugs | 540 out of 786 | 31st |
Industry Pharmaceutical Preparations | 417 out of 571 | 27th |
Source: SEC filing on April 21, 2014.
Berkman's colleagues
We found three more compensation records of executives who worked with Charles S. Berkman at Ligand Pharmaceuticals in 2011.